The FDA approved around 21 drugs in 2010, a relatively modest figure, with some of the most...

|By:, SA News Editor

The FDA approved around 21 drugs in 2010, a relatively modest figure, with some of the most highly anticipated products delayed into next year or beyond. Among this year's FDA-approval winners: Amgen (AMGN), Roche (RHHBY.PK), Novartis (NVS), Acorda (ACOR) and Dendreon (DNDN).